Introduction
Alzheimer's disease (AD) is a neurodegenerative disorder histopathologically characterized by the abundance of proteinaceous deposits in the cerebral cortex and hippocampus of affected individuals, extracellularly as senile plaques and intracellularly as neurofibrillary tangles (Müller-Hill & Beyreuther 1989) . The major component in plaques is the βA4-amyloid protein, a ~4 kD amyloidogenic peptide (Glenner & Wong 1984 , Masters et al. 1985 , derived from a larger transmembrane glycoprotein termed the βA4-amyloid protein precursor (APP) (Kang et al. 1987) . APP constitutes a family of alternatively spliced isoforms with 770, 752, 751, 733, 714, 696, 695 and 677 amino acids as a result of alternative splicing of exons 7, 8 and 15 (Sandbrink et al. 1994a) . The four largest isoforms contain a domain structurally and functionally homologous to the Kunitz family of protease inhibitors (KPI; Kitaguchi et al. 1987 , Ponte et al. 1988 , Tanzi et al. 1988 that is encoded by exon 7 of the APP gene (Yoshikai et al. 1990) . Exon 8 encoding a domain with homology to the MRC OX-2 antigen (Clark et al. 1985) is also alternatively spliced: this domain is present in the two largest APP isoforms and in the two only weakly expressed APP isoforms with 714 and 696 amino acids (Golde et al. 1990 , Kang & Müller-Hill 1990 .
Exon 15 was then identified as the third alternatively spliced exon in APP transcripts encoding for transmembrane APP isoforms. This exon encodes a domain preceding the NH 2 -terminus of the βA4-region of APP, encoded
